COVID-19

In this article the authors aimed to analyse the range and prevalence of neurological and psychiatric complications associated with paediatric SARS-CoV-2 infection in hospitalised children and adolescents.

This paper aims to evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation from March 2020 to December 2020, and to investigate the association of SARS-CoV2 and Bell's palsy.

Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology

In this article the authors reviewed the scientific literature on movement disorders associated with Covid-19 published in English, spanning from the initial descriptions of COVID-19.

The objective of this multicentre retrospective cohort study was to develop and validate models that predict mortality of patients diagnosed with COVID-19 admitted to the hospital.

The objective of this study was to estimate the frequency of headache in patients with confirmed COVID-19 and characterize the phenotype of headache attributed to COVID-19, comparing patients depending on sex and the need for hospitalisation.

The aim of this study was to report orbital and visual pathways MRI findings in a nationwide multicenter cohort of patients with severe COVID-19.

COVID-19 has been associated with various neurological and atypical HEENT (head/eyes/eyes/nose/throat) manifestations. In this systematic review and meta-analysis the authors sought to review the evidence for these manifestations.

For August 2021, we have selected two COVID-19 papers of the month, investigating the effectiveness of the Covid-19 vaccines in England and Israel, respectively.

In this article the authors describe the case of a COVID-19 patient who developed bilateral occipital lobe haemorrhages suggestive of haemorrhagic PRES.

In this article the authors aimed to investigate the consequences of the first COVID-19 lockdown (mid-March - mid-April 2020) on motor and non-motor symptoms (NMS) in a cohort of French people with Parkinson's disease (PwP).

In this article the authors aimed to evaluate the effects of the COVID-19 pandemic on the quality of life (QoL) and perceived disease burden of this group of patients.

In this article the authors aimed to describe the neuropathological findings in SARS-CoV-2 infected patients who died during the COVID-19 pandemic, and define and quantify the presence of virus in selected areas showing pathological signs.

In this study, the authors analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19.

In this article the authors report two male patients, aged 45 and 67, who developed a classical form of PD approximately three months after a moderate COVID-19 infection with dyspnea, fever, anosmia and ageusia.